Patent US4021544A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4021544A Expired / Lapsed US ⏱️ 0.0 years remaining

Complement inhibitors

Assignee: Wyeth Holdings LLC
•
Filing: 1976-07-12
•
Granted: 1977-05-03
•
Expires: 1996-07-12
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Sulfated oligosaccharides of the maltose series useful as complement inhibitors.

Inventors

  • 👤 Vijay Gopalan Nair
  • 👤 Joseph Peter Joseph
  • 👤 Seymour Bernstein

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-26 19:07
CPC Classifications
C; C07; C07H; C07H11/00; A; A61; A61K; A61K31/00; A61K31/70; A61P; A61P29/00; A61P37/00; A61P37/02; A61P37/06; A61P37/08; A61P7/00

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 76 words
A method of inhibiting the complement system in a body fluid which comprises subjecting said body fluid to the action of an effective complement inhibiting amount of a compound selected from those of the formula: ##STR2## wherein M represents hydrogen or the salt of an alkali metal, alkaline earth metal, ammonia, triloweralkylamine (C 1 -C 6 ), piperidine, pyrazine, alkanolamine (C 1 -C 6 ); and cycloalkanolamine (C 3 -C 6 ); and n is 2-10.
Claim 2
Independent Claim 76 words
A method of inhibiting the complement system in a body fluid which comprises subjecting said body fluid to the action of an effective complement inhibiting amount of a compound selected from those of the formula: ##STR2## wherein M represents hydrogen or the salt of an alkali metal, alkaline earth metal, ammonia, triloweralkylamine (C 1 -C 6 ), piperidine, pyrazine, alkanolamine (C 1 -C 6 ); and cycloalkanolamine (C 3 -C 6 ); and n is 2-10.
Claim 3
Dependent Claim 21 words
A method according to claim 1 wherein n is 2-10 and M is selected from the group comprising trimethylamine and sodium.
Claim 4
Dependent Claim 13 words
A method according to claim 1 wherein the body fluid is blood serum.
Claim 5
Independent Claim 73 words
A method of inhibiting the complement system in a warm-blooded animal which comprises internally administering to said animal an effective complement inhibiting amount of a compound selected from those of the formula ##STR3## wherein M represents hydrogen or the salt of an alkali metal, alkaline earth metal, ammonia, triloweralkylamine (C 1 -C 6 ), piperidine, pyrazine, alkanolamine (C 1 -C 6 ); and cycloalkanolamine (C 3 -C 6 ); and n is 2-10.
Claim 6
Independent Claim 73 words
A method of inhibiting the complement system in a warm-blooded animal which comprises internally administering to said animal an effective complement inhibiting amount of a compound selected from those of the formula ##STR3## wherein M represents hydrogen or the salt of an alkali metal, alkaline earth metal, ammonia, triloweralkylamine (C 1 -C 6 ), piperidine, pyrazine, alkanolamine (C 1 -C 6 ); and cycloalkanolamine (C 3 -C 6 ); and n is 2-10.
Claim 7
Dependent Claim 12 words
A method according to claim 4 wherein the compound is administered intra-articularly.
Claim 8
Dependent Claim 21 words
A method according to claim 4 wherein n is 2-10 and M is selected from the group comprising trimethylamine and sodium.

References Cited (Backward Citations)

US3911915A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1980-05-02 1980-11-01 1981-05-03 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1984-05-02 1984-11-01 1985-05-03 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1988-05-02 1988-11-01 1989-05-03 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag